Translating The Foreign Corrupt Practices Act Into Practice: DOJ/SEC Offer Pragmatic Enforcement Guide
This article was originally published in The Gray Sheet
Executive Summary
The FCPA resource guide gives examples of cases the DOJ and SEC have decided not to prosecute and describes the hallmarks of an effective compliance program. AdvaMed was among groups that asked for more clarity.
You may also be interested in...
Foreign Corrupt Practices Act: Device Industry Under Scrutiny
Federal prosecutors have begun targeting medical device companies in Foreign Corrupt Practices Act investigations
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.